Guy M. Bormans
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
Selective CXCR4-Targeting Radioconjugates Derived from LY2510924: Evaluation of [18F]AlF-NOTA-SC, [177Lu]Lu-BL02, and [161Tb]Tb-BL02 for Theranostic Development.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 01, 2026
Evaluation of [¹⁸F]AlF-NOTA-octreotide PET/CT in routine clinical use: a retrospective analysis in 288 neuroendocrine tumor patients.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 16, 2026
Affinity- and Format-Dependent Pharmacokinetics of 89Zr-Labeled Albumin-Binding VHH Constructs.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 26, 2025
[11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeutics.
Journal: EJNMMI radiopharmacy and chemistry
Published: June 24, 2025
In vivo imaging of heat shock protein 90: Diagnostic tool and support for Hsp90-targeted therapy.
Journal: Cell stress & chaperones
Published: June 20, 2025
Dosimetry and kinetic modelling of [18F]JNJ-64511070, a novel PET ligand to quantify AMPA-associated TARP-γ8 receptors in the human brain.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 19, 2025
Radiosynthesis and Evaluation of [18F]FEHSP990 as Novel PET Tracer for Hsp90 PET Imaging.
Journal: Journal of labelled compounds & radiopharmaceuticals
Published: January 23, 2025
Development and evaluation of Hsp90-targeting nanobodies for visualisation of extracellular Hsp90 in tumours using PET imaging.
Journal: EJNMMI radiopharmacy and chemistry
Published: December 19, 2024
PET imaging with [¹¹C]CHDI-00485180-R, designed as radioligand for aggregated mutant huntingtin, in people with Huntington's disease.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 16, 2024
Last Updated: 09/26/2026